DSM: Barclays raises target price

(CercleFinance.com) - Barclays reinstates its "overweight" rating on the DSM share, while raising its target price by 10% to 125 euros, in a report in which it updates its forecasts for eight European chemists in order to reflect the latest market conditions ahead of Q2 results.


Regarding DSM, the broker has reduced its 2020 forecasts for the materials business, due to lower sales to the automobile and protection markets. However, it raises its 2021 EBITDA estimate by 5%, mainly due to the recent acquisition of Erber.


Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.